Nortem Biogroup (XPAR:MLBIO) Liabilities-to-Assets : 0.51 (As of Dec. 2022)

View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Nortem Biogroup's Total Liabilities for the quarter that ended in Dec. 2022 was €6.85 Mil. Nortem Biogroup's Total Assets for the quarter that ended in Dec. 2022 was €13.47 Mil. Therefore, Nortem Biogroup's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 was 0.51.

Nortem Biogroup Liabilities-to-Assets Historical Data

The historical data trend for Nortem Biogroup's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Liabilities-to-Assets Chart

Nortem Biogroup Annual Data

Trend

Dec21

Dec22

Liabilities-to-Assets

0.46

0.51

Nortem Biogroup Semi-Annual Data
	Dec21	Dec22
Liabilities-to-Assets	0.46	0.51

Competitive Comparison of Nortem Biogroup's Liabilities-to-Assets

For the Packaged Foods subindustry, Nortem Biogroup's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nortem Biogroup's Liabilities-to-Assets Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Nortem Biogroup's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Nortem Biogroup's Liabilities-to-Assets falls into.

Nortem Biogroup Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Nortem Biogroup's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Liabilities-to-Assets (A: Dec. 2022 )	=	Total Liabilities	/	Total Assets
	=	6.852	/	13.468
	=	0.51

Nortem Biogroup's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2022 is calculated as

Liabilities-to-Assets (Q: Dec. 2022 )	=	Total Liabilities	/	Total Assets
	=	6.852	/	13.468
	=	0.51

Nortem Biogroup (XPAR:MLBIO) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.

Nortem Biogroup Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nortem Biogroup (XPAR:MLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Liabilities-to-Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500

Website

https://www.nortembiogroup.com

Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines